Dosidal · Belgium

Co-Losartan AB 50 mg - 12.5 mg

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:344583-02 (version 1)
Levelpresentation
Pack codebe-cnk (Belgian national): 2680452
Identifiersbe-cti-extended: 344583-02
be-cnk: 2680452
be-authorisation: BE344583
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: AUTHORIZED
ampp_status: AUTHORIZED
commercialised_now: False
lifecycle: current
period_from: 2023-01-27
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM344583-00
atc: C09DA01
authorisation_number: BE344583
cti_extended: 344583-02
form: Film-coated tablet
holder: Aurobindo
medicine_type: ALLOPATHIC
name: Co-Losartan AB 50 mg - 12.5 mg
pack: 28
parallel_circuit: 0
parallel_import: False
substances: strength: 50.0100 mg
substance: Losartan Potassium; strength: 12.5000 mg
substance: Hydrochlorothiazide
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codecnk_public: 2680452
fmd_in_scope: True
note: no FMD product code in SAM for this pack: the maker's GTIN is not published
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006
class: prescription
delivery_modus: M1
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
MzB13OEzFZVYe5po9IIl8I8bLAveSPWldCoThzq8tLE8GGL0_1k6u-VQHY_s6pK00vdhtx3F4UTAp30YDl1-lg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:344583-02 · Related records in other markets · Dosidal